Compare AMPH & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | AXGN |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2014 | N/A |
| Metric | AMPH | AXGN |
|---|---|---|
| Price | $25.25 | $30.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | $31.00 | ★ $33.67 |
| AVG Volume (30 Days) | 374.8K | ★ 992.8K |
| Earning Date | 11-06-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.27 | N/A |
| Revenue | ★ $723,305,000.00 | $214,709,000.00 |
| Revenue This Year | $1.35 | $21.57 |
| Revenue Next Year | $5.10 | $15.79 |
| P/E Ratio | $11.14 | ★ N/A |
| Revenue Growth | N/A | ★ 18.72 |
| 52 Week Low | $20.39 | $9.22 |
| 52 Week High | $45.39 | $34.24 |
| Indicator | AMPH | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 42.84 | 64.32 |
| Support Level | $25.22 | $28.88 |
| Resistance Level | $27.84 | $34.24 |
| Average True Range (ATR) | 0.80 | 1.54 |
| MACD | -0.22 | -0.16 |
| Stochastic Oscillator | 2.56 | 49.59 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.